BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 33297481)

  • 1. Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
    Fetter T; Niebel D; Braegelmann C; Wenzel J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin.
    Bacalao MA; Satterthwaite AB
    Front Immunol; 2020; 11():615673. PubMed ID: 33519824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.
    Das D; Akhtar S; Kurra S; Gupta S; Sharma A
    Cytokine Growth Factor Rev; 2019 Feb; 45():35-44. PubMed ID: 30773437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
    Katsuyama T; Tsokos GC; Moulton VR
    Front Immunol; 2018; 9():1088. PubMed ID: 29868033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lived plasma cells and their contribution to autoimmunity.
    Hoyer BF; Manz RA; Radbruch A; Hiepe F
    Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
    Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BAFF: A regulatory cytokine of B lymphocytes involved in autoimmunity and lymphoid cancer].
    Reyes S LI; León B F; Rozas V MF; González J P; Naves P R
    Rev Med Chil; 2006 Sep; 134(9):1175-84. PubMed ID: 17171221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes as therapeutic targets in systemic lupus erythematosus.
    Hasler P; Zouali M
    Expert Opin Ther Targets; 2006 Dec; 10(6):803-15. PubMed ID: 17105369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive T-Lymphocytes in Inflammatory Skin Diseases.
    Boehncke WH; Brembilla NC
    Front Immunol; 2019; 10():1198. PubMed ID: 31191553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral immature B cells: modulators of autoimmunity.
    Lee J; Sim JH; Kim IJ
    Int J Rheum Dis; 2015 Feb; 18(2):200-7. PubMed ID: 25292255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive T cells and their role in atopic dermatitis.
    De Bruyn Carlier T; Badloe FMS; Ring J; Gutermuth J; Kortekaas Krohn I
    J Autoimmun; 2021 Jun; 120():102634. PubMed ID: 33892348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell targeted therapies in autoimmune disease.
    Barnas JL; Looney RJ; Anolik JH
    Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases.
    Zhou S; Li Q; Wu H; Lu Q
    Cell Mol Immunol; 2020 Apr; 17(4):335-346. PubMed ID: 32203190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.